Breast Cancer Research · 2001 · 39 citations · 20 references
MedicineGeneticsOncologyCancer GeneticsTumor HeterogeneityTumor ProgressionCancer CytogeneticsCancer GenomicsGenetic HeterogeneityIntertumoral HeterogeneityIntratumoral HeterogeneityLoss Of HeterozygosityBreast Cancer GenomicsChromosome 17Q LossChromosome 18Q LossHeterogeneityIntratumor Genetic HeterogeneityIntratumor HeterogeneityLoss Of Heterozygosity AnalysisTumor Heterogeneity Assessment
We examined the stage specificity and heterogeneity of 18p11 alterations in a series of tumors representing 96 microdissected samples. Significant loss of heterozygosity (LOH) (63%) was found, with 56% occurring early in ductal carcinoma in situ. Although most cases indicated LOH was clonally inherited, heterogeneity for 18p LOH occurred in 27% of tumors. When compared with other LOH data, 18p LOH was found in conjunction with allelic deletion on 3p, 9p, 17p and 17q, while 13q, 16q, and 11p were less frequently associated. These analyses suggest chromosome 18p11 alteration is a common and early event in breast disease.
20
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Tsutomu Nobori, Kaoru Miura, David Wu et al. · Nature · 1994 · 1.8K citations
Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
Guoren Deng, You Lü, G Zlotnikov et al. · Science · 1996 · 587 citations
Ductal Carcinoma In Situ of the Female Breast
Gyda Lolk Ottesen, H.P. Graversen, M Blichert-Toft et al. · The American Journal of Surgical Pathology · 1992 · 159 citations